The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
(Score: 0) by Anonymous Coward on Saturday December 17 2016, @02:46PM
by Anonymous Coward
on Saturday December 17 2016, @02:46PM (#29653)
Figure 3
Establishment of In Vivo Induction Protocol in 4F Mice
(A) Body weight of 4F mice upon continuous administration of doxycycline (−Dox n = 11; +Dox n = 26).
Figure 4
Extension of Lifespan and Prevention of Age-Associated Phenotypes by In Vivo Induction of Oct4, Sox2, Klf4, and c-Myc
(A) Body weight of LAKI and LAKI 4F mice upon cyclic doxycycline administration. LAKI (−Dox n = 20; +Dox n = 13) and LAKI 4F (−Dox n = 18; +Dox n = 15).
(G) ECG analysis in LAKI 4F mice upon cyclic doxycycline administration (−Dox n = 4; +Dox n = 4). Heart rate represented as beats per minute (bpm). ∗p
Figure 7
Improved Resistance to Metabolic Disease and Skeletal Muscle Injury in Aged WT Animals by In Vivo Reprogramming
(B) Glucose tolerance test (GTT) in 12-month-old WT 4F mice following beta cell ablation by low dose STZ (−Dox n = 6; +Dox n = 6). ∗∗p
Figure S3
Effect of Long-Term In Vivo Cyclic Induction of Oct4, Sox2, Klf4, and c-Myc in Mice Carrying One and Two Copies of OSKM and rtTA Cassette, Related to Figure 3
(A) Body weight of wild-type (WT) and 4F mice carrying single copy of OSKM and rtTA cassette upon cyclic administration of doxycycline. WT (n = 5) and 4F (n = 3).
Figure S7
Analysis of Pancreatic Function and Skeletal Muscle Regeneration in Wild-Type Mice, Related to Figure 7
(A) Glucose tolerance test (GTT) in 2-month and 12-month old WT mice following beta cell ablation by low dose (50 mg/kg) STZ (2-month WT n = 3; 12-month WT n = 3).
(D) GTT in 12-month old WT mice following doxycycline and beta cell ablation by low dose (50 mg/kg) STZ (-Dox n = 5; +Dox n = 5).
(I) Quantification of percentage of central nucleated fibers in muscle sections of 12-month old WT mice following doxycycline treatment and muscle injury by CTX injection (-Dox n = 3; +Dox n = 3).
(Score: 0) by Anonymous Coward on Saturday December 17 2016, @02:46PM
Figure 3
Figure 4